1. Sanchez A, Reeser JL, Lau HS, et al. Role of sugars in human
neutrophilic phagocytosis. Am J Clin Nutr 1973;26:1180–4.
2. Ringsdorf WM, Cheraskin E, Ramsay RR. Sucrose, neutrophilic
phagocytosis and resistance to disease. Dent Survey 1976;52(12):46.
3. Nutter RL, Gridley DS, Kettering JD, et al. Modification of a
transplantable colon tumor and immune responses in mice fed different sources of protein, fat
and carbohydrate. Cancer Lett 1983;18(1):49–62.
4. Kos WL, Kos KA, Kaplan AM. Impaired function of immune reactivity to
Listeria monocytogenes in diet-fed mice. Infect Immun 1984;43:1094–6.
5. Ahmed FE. Toxicological effects of ethanol on human health. Crit
Rev Tox 1995;25(4):347–67.
6. Szabo G. Monocytes, alcohol use, and altered immunity. Alcohol
Clin Exp Res 1998;22:216–9S.
7. Seitz HK, Poschl G, Simanowski UA. Alcohol and cancer. Recent Dev
Alcohol 1998;14:67–95 [review].
8. MacGregor RR, Louria DB. Alcohol and infection. Curr Clin Top
Infect Dis 1997;17:291–315 [review].
9. Balla AK, Lischner HW, Pomerantz RJ, et al. Human studies on alcohol
and susceptibility to HIV infection. Alcohol 1994;11:99–103 [review].
10. Engs RC, Aldo-Benson M. The association of alcohol consumption with
self-reported illness in university students. Psychol Rep 1995;76:727–36.
11. Cohen S, Tyrrell DA, Russell MA, et al. Smoking, alcohol consumption,
and susceptibility to the common cold. Am J Public Health 1993;83:1277–83.
12. Kelley DS, Daudu PA. Fat intake and immune response. Prog Food
Nutr Sci 1993;17:41–63 [review].
13. Yaqoob P. Monounsaturated fats and immune function. Proc Nutr
Soc 1998;57:511–20 [review].
14. Tashiro T, Yamamori H, Takagi K, et al. n-3 versus n-6
polyunsaturated fatty acids in critical illness. Nutrition 1998;14:551–3.
15. Gerster H. The use of n-3 PUFAs (fish oil) in enteral nutrition.
Int J Vitam Nutr Res 1995;65:3–20 [review].
16. Meydani SN, Lichtenstein AH, Cornwall S, et al. Immunologic effects
of national cholesterol education panel step-2 diets with and without fish-derived n-3 fatty
acid enrichment. J Clin Invest 1993;92:105–13.
17. Kelley DS, Taylor PC, Nelson GJ, et al. Docosahexaenoic acid
ingestion inhibits natural killer cell activity and production of inflammatory mediators in
young healthy men. Lipids 1999;34:317–24.
18. Wu D, Meydani SN. n-3 polyunsaturated fatty acids and immune
function. Proc Nutr Soc 1998;57:503–9 [review].
19. Kelley DS, Dougherty RM, Branch LB, et al. Concentration of dietary
N-6 polyunsaturated fatty acids and the human immune status. Clin Immunol
Immunopathol 1992;62:240–4.
20. Rasmussen LB, Kiens B, Pedersen BK, et al. Effect of diet and plasma
fatty acid composition on immune status in elderly men. Am J Clin Nutr
1994;59:572–7.
21. Wan JM, Teo TC, Babayan VK, et al. Invited comment: lipids and the
development of immune dysfunction and infection. JPEN J Parenter Enteral Nutr
1988;12:43S–52S.
22. Meydani SN, Ha WK. Immunologic effects of yogurt. Am J Clin
Nutr 2000;71:861–72 [review].
23. Chandra RK. Nutrition and the immune system: an introduction. Am
J Clin Nutr 1997;66:460–3S [review].
24. Stallone DD. The influence of obesity and its treatment on the immune
system. Nutr Rev 1994;52:37–50.
25. Nieman DC, Nehlsen-Cannarella SI, Henson DA, et al. Immune response
to obesity and moderate weight loss. Int J Obes Relat Metab Disord
1996;20:353–60.
26. Nieman DC, Henson DA, Nehlsen-Cannarella SL. Influence of obesity on
immune function. J Am Diet Assoc 1999;99:294–9.
27. Scanga CB, Verde TJ, Paolone AM, et al. Effects of weight loss and
exercise training on natural killer cell activity in obese women. Med Sci Sports
Exerc 1998;30:1666–71.
28. Nieman DC. Exercise immunology: practical applications. Int J
Sports Med 1997;18:S91–100 [review].
29. Nieman DC. Exercise and resistance to infection. Can J Physiol
Pharmacol 1998;76:573–80 [review].
30. Shephard RJ, Shek PN. Associations between physical activity and
susceptibility to cancer: possible mechanisms. Sports Med 1998;26:293–315
[review].
31. Meydani SN, Barklund MP, Liu S, et al. Vitamin E supplementation
enhances cell-mediated immunity in healthy elderly subjects. Am J Clin Nutr
1990;52:557–63.
32. Meydani SN, Meydani M, Blumberg JB, et al. Vitamin E supplementation
and in vivo immune response in healthy elderly subjects: a randomized controlled trial.
JAMA 1997;277:1380–6.
33. De Waart FG, Portengen L, Doekes G, et al. Effect of 3 months vitamin
E supplementation on indices of the cellular and humoral immune response in elderly subjects.
Br J Nutr 1997;78:761–74.
34. Chew BP. Role of carotenoids in the immune response. J Dairy
Sci 1993;76:2804–11.
35. Bendich A. Beta-carotene and the immune response. Proc Nutr
Soc 1991;50:263–74.
36. Hughes DA, Wright AJ, Finglas PM, et al. The effect of beta-carotene
supplementation on the immune function of blood monocytes from healthy male nonsmokers. J
Lab Clin Med 1997;129:309–17.
37. Murata T, Tamai H, Morinobu T, et al. Effect of long-term
administration of beta-carotene on lymphocyte subsets in humans. Am J Clin Nutr
1994;60:597–602.
38. Santos MS, Meydani SN, Leka L, et al. Natural killer cell activity in
elderly men is enhanced by beta-carotene supplementation. Am J Clin Nutr
1996;64:772–7.
39. Santos MS, Leka LS, Ribaya-Mercado JD, et al. Short- and long-term
beta-carotene supplementation do not influence T cell-mediated immunity in healthy elderly
persons. Am J Clin Nutr 1997;66:917–24.
40. Kazi N, Radvany R, Oldham T, et al. Immunomodulatory effect of
beta-carotene on T lymphocyte subsets in patients with resected colonic polyps and cancer.
Nutr Cancer 1997;28:140–5.
41. Fuller CJ, Faulkner H, Bendich A, et al. Effect of beta-carotene
supplementation on photosuppression of delayed-type hypersensitivity in normal young men.
Am J Clin Nutr 1992;56:684–90.
42. Coodley GO, Coodley MK, Lusk R, et al. Beta-carotene in HIV
infection: an extended evaluation. AIDS 1996;10:967–73.
43. Fryburg DA, Mark RJ, Griffith BP, et al. The effect of supplemental
beta-carotene on immunologic indices in patients with AIDS: a pilot study. Yale J Biol
Med 1995;68:19–23.
44. Gerber WF, Lefkowitz SS, Hung CY. Effect of ascorbic acid, sodium
salicylate, and caffeine on the serum interferon level in response to viral infection.
Pharmacology 1975;13:228.
45. Anderson R. The immunostimulatory, anti-inflammatory an anti-allergic
properties of ascorbate. Adv Nutr Res 1984;6:19–45 [review].
46. Banic S. Immunostimulation by vitamin C. Int J Vitam Nutr Res
Suppl 1982;23:49–52 [review].
47. Delafuente JC, Prendergast JM, Modigh A. Immunologic modulation by
vitamin C in the elderly. Int J Immunopharmacol 1986;8:205–11.
48. Kennes B, Dumont I, Brohee D, et al. Effect of vitamin C supplements
on cell-mediated immunity in old people. Gerontology 1983;29:305–10.
49. Murata A. Virucidal activity of vitamin C for prevention and
treatment of viral diseases. In Proceedings of the First Intersectional Congress of IAMS, vol
3. Science Council Japan, 1975, 432.
50. Knodell RG, Tate MA, Akl BF, et al. Vitamin C prophylaxis for
posttransfusion hepatitis: Lack of effect in a controlled trial. Am J Clin Nutr
1981;34(1):20–3.
51. Hemilä H. Vitamin C and the common cold. Br J Nutr
1992;67:3–16.
52. Hemilä H. Vitamin C and common cold incidence: a review of
studies with subjects under heavy physical stress. Int J Sports Med
1996;17:379–83.
53. Semba RD. Vitamin A, immunity, and infection. Clin Infect
Dis 1994;19:489–99 [review].
54. Glasziou PP, Mackerras DEM. Vitamin A supplementation in infectious
diseases: a meta-analysis. BMJ 1993;306:366–70.
55. Stephensen CB, Franchi LM, Hernandez H, et al. Adverse effects of
high-dose vitamin A supplements in children hospitalized with pneumonia. Pediatrics
1998;101(5):E3 [abstract].
56. Bresee JS, Fischer M, Dowell SF, et al. Vitamin A therapy for
children with respiratory syncytial virus infection: a multicenter trial in the United States.
Pediatr Infect Dis J 1996;15:777–82.
57. Quinlan KP, Hayani KC. Vitamin A and respiratory syncytial virus
infection. Serum levels and supplementation trial. Arch Pediatr Adolesc Med
1996;150:25–30.
58. Kjolhede CL, Chew FJ, Gadomski AM, et al. Clinical trial of vitamin A
as adjuvant treatment for lower respiratory tract infections. J Pediatr
1995;126:807–12.
59. Pinnock CB, Douglas RM, Badcock NR. Vitamin A status in children who
are prone to respiratory tract infections. Aust Paediatr J 1986;22:95–9.
60. Murphy S, West KP Jr, Greenough WB 3d, et al. Impact of vitamin A
supplementation on the incidence of infection in elderly nursing-home residents: a randomized
controlled trial. Age Ageing 1992;21:435–9.
61. Fawzi WW, Mbise R, Spiegelman D, et al. Vitamin A supplements and
diarrheal and respiratory tract infections among children in Dar es Salaam, Tanzania. J
Pediatr 2000;137:660–7.
62. Ross AC. Vitamin A supplementation as therapy--are the benefits
disease specific? Am J Clin Nutr 1998;68:8–9 [review].
63. Fawzi WW, Mbise RL, Fataki MR, et al. Vitamin A supplementation and
severity of pneumonia in children admitted to the hospital in Dar es Salaam, Tanzania. Am
J Clin Nutr 1998;68:187–92.
64. American Academy of Pediatrics Committee on Infectious Diseases.
Vitamin A treatment of measles. Pediatrics 1993,91:1014–5.
65. Penn ND, Purkins L, Kelleher J, et al. The effect of dietary
supplementation with vitamins A, C and E on cell-mediated immune function in elderly long-stay
patients: a randomized controlled trial. Age Ageing 1991;20:169–74.
66. de la Fuente M, Ferrandez MD, Burgos MS, et al. Immune function in
aged women is improved by ingestion of vitamins C and E. Can J Physiol Pharmacol
1998;76:373–80.
67. Jones C, Palmer TE, Griffiths RD. Randomized clinical outcome study
of critically ill patients given glutamine-supplemented enteral nutrition. Nutrition
1999;15:108–15.
68. Griffiths RD. Outcome of critically ill patients after
supplementation with glutamine. Nutrition 1997;13:752–4 [review].
69. Nieman DC. Exercise and resistance to infection. Can J Physiol
Pharmacol 1998;76:573–80 [review].
70. Rohde T, MacLean DA, Pedersen BK. Effect of glutamine supplementation
on changes in the immune system induced by repeated exercise. Med Sci Sports Exerc
1998;30:856–62.
71. Castell LM, Newsholme EA. Glutamine and the effects of exhaustive
exercise upon the immune response. Can J Physiol Pharmacol 1998;76:524–32
[review].
72. Castell LM, Poortmans JR, Newsholme EA. Does glutamine have a role in
reducing infections in athletes? Eur J Appl Physiol 1996;73:488–90.
73. Fernandes CF, Shahani KM, Amer MA. Therapeutic role of dietary
lactobacilli and lactobacillic fermented dairy products. FEMS Micro Rev
1987;46:343–56.
74. Bengmark S. Immunonutrition: role of biosurfactants, fiber, and
probiotic bacteria. Nutrition 1998;14:585–94 [review].
75. Phuapradit P, Varavithya W, Vathanophas K, et al. Reduction of
rotavirus infection in children receiving bifidobacteria-supplemented formula. J Med Assoc
Thai 1999;82:S43–8.
76. Pedone CA, Arnaud CC, Postaire ER, et al. Multicentric study of the
effect of milk fermented by Lactobacilus casei on the incidence of diarrhea. Int J Clin
Pract 2000;54:568–71.
77. Saavedra J. Probiotics and infectious diarrhea. Am J
Gastroenterol 2000;95:S16–8.
78. Fiocchi A, Borella E, Riva E, et al. A double-blind clinical trial
for the evaluation of the therapeutic effectiveness of a calf thymus derivative (Thymomodulin)
in children with recurrent respiratory infections. Thymus 1986;8:831–9.
79. Galli L, de Martino M, Azzari C, et al. Preventive effect of
thymomodulin in recurrent respiratory infections in children. Pediatr Med Chir
1990;12:229–32.
80. Vettori G, Lazzaro A, Mazzanti P, Cazzola P. Prevention of recurrent
respiratory infections in adults. Minerva Med 1987;78:1281–9.
81. Longo F, Lepore L, Agosti E, Panizon F. Evaluation of the
effectiveness of thymomodulin in children with recurrent respiratory infections. Pediatr
Med Chir 1988;10:603–7.
82. Maiorano V, Chianese R, Fumarulo R, et al. Thymomodulin increases the
depressed production of superoxide anion by alveolar macrophages in patients with chronic
bronchitis. Int J Tissue React 1989;11:21–5.
83. Garagiola U, Buzzetti M, Cardella E. Immunological patterns during
regular intensive training in athletes: quantification and evaluation of a preventive
pharmacological approach. J Int Med Res 1995;23:85–95.
84. Wysocki J, Wierusz-Wysocka B, Wykretowicz A, Wysocki H. The influence
of thymus extracts on the chemotaxis of polymorphonuclear neutrophils (PMN) from patients with
insulin-dependent diabetes mellitus (IDD). Thymus 1992;20:63–7.
85. Calsini P, Mocchegiani E, Fabris N. The pharmacodynamics of
thymomodulin in elderly humans. Drugs Exp Clin Res 1985;11:671–4.
86. Braga PC, Dal Sasso M, Maci S, et al. Restoration of
polymorphonuclear leukocyte function in elderly subjects by thymomodulin. J Chemother
1994;6:354–9.
87. Duchateau J, Delespesse G, Vereecke P. Influence of oral zinc
supplementation on the lymphocyte response to mitogens of normal subjects. Am J Clin
Nutr 1981;34:88–93.
88. Fraker PJ, Gershwin ME, Good RA, Prasad A. Interrelationships between
zinc and immune function. Fed Proc 1986;45:1474–9.
89. Fortes C, Forastiere F, Agabiti N, et al. The effect of zinc and
vitamin A supplementation on immune response in an older population. J Am Geriatr Soc
1998;46:19–26.
90. Girodon F, Lombard M, Galan P, et al. Effect of micronutrient
supplementation on infection in institutionalized elderly subjects: a controlled trial.
Ann Nutr Metab 1997;41:98–107.
91. Chandra RK. Excessive intake of zinc impairs immune responses.
JAMA 1984;252:1443–6.
92. Macknin ML. Zinc lozenges for the common cold. Cleveland Clin J
Med 1999;66:27–32 [review].
93. Corridan BM, O’Donohue MP, Morrissey PA. Carotenoids and immune
response in elderly people. Proc Nutr Soc 1998;57:3A–4A.
94. Tamura J, Kubota K, Murakami H, et al. Immunomodulation by vitamin
B12: augmentation of CD8+ T lymphocytes and natural killer (NK) cell activity in vitamin
B12-deficient patients by methyl-B12 treatment. Clin Exp Immunol
1999;116:28–32.
95. Czop JK. The role of beta-glucan receptors on blood and tissue
leukocytes in phagocytosis and metabolic activation. Pathol Immunopathol Res
1986;5:286–96.
96. Wakshull E, Brunke-Reese D, Lindermuth J, et al. PGG-glucan, a
soluble beta-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and
activates an NF-kappa B-like factor in human PMN: evidence for a glycosphingolipid
beta-(1,3)-glucan receptor. Immunopharmacology 1999;41:89–107.
97. Czop JK, Kay J. Isolation and characterization of beta-glucan
receptors on human mononuclear phagocytes. J Exp Med 1991;173:1511–20.
98. Czop JK, Puglisi AV, Miorandi DZ, Austen KF. Perturbation of
beta-glucan receptors on human neutrophils initiates phagocytosis and leukotriene B4
production. J Immunol 1988;141:3170–6.
99. Estrada A, Yun CH, Van Kessel A, et al. Immunomodulatory activities
of oat beta-glucan in vitro and in vivo. Microbiol Immunol 1997;41:991–8.
100. Ooi VE, Liu F. Immunomodulation and anti-cancer activity of
polysaccharide-protein complexes. Curr Med Chem 2000;7:715–29 [review].
101. Ross GD, Vetvicka V, Yan J, et al. Therapeutic intervention with
complement and beta-glucan in cancer. Immunopharmacology 1999;42:61–74.
102. Di Renzo L, Yefenof E, Klein E. The function of human NK cells is
enhanced by beta-glucan, a ligand of CR3 (CD11b/CD18). Eur J Immunol
1991;21:1755–8.
103. Khorram O, Vu L, Yen SS. Activation of immune function by
dehydroepiandrosterone (DHEA) in age-advanced men. J Gerontol A Biol Sci Med Sci
1997;52:M1–7.
104. Casson PR, Andersen RN, Herrod HG, et al. Oral
dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women.
Am J Obstet Gynecol 1993;169:1536–9.
105. Caughey GE, Mantzioris E, Gibson RA, et al. The effect on human
tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty
acids from vegetable oil or fish oil. Am J Clin Nutr 1996;63:116–22.
106. Endres S, Meydani SN, Ghorbani R, et al. Dietary supplementation
with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation.
J Leukoc Biol 1993;54:599–603.
107. Meydani SN, Endres S, Woods MM, et al. Oral (n-3) fatty acid
supplementation suppresses cytokine production and lymphocyte proliferation: comparison
between young and older women. J Nutr 1991;121:547–55.
108. Virella G, Fourspring K, Hyman B, et al. Immunosuppressive effects
of fish oil in normal human volunteers: correlation with the in vitro effects of
eicosapentanoic acid on human lymphocytes. Clin Immunol Immunopathol
1991;61:161–76.
109. Wu D, Meydani SN. n-3 polyunsaturated fatty acids and immune
function. Proc Nutr Soc 1998;57:503–9 [review].
110. Kudsk KA, Minard G, Croce MA, et al. A randomized trial of
isonitrogenous enteral diets after severe trauma. An immune-enhancing diet reduces septic
complications. Ann Surg 1996;224:531–40.
111. Braga M, Gianotti L, Cestari A, et al. Gut function and immune and
inflammatory responses in patients perioperatively fed with supplemented enteral formulas.
Arch Surg 1996;131:1257–64.
112. Kemen M, Senkal M, Homann HH, et al. Early postoperative enteral
nutrition with arginine-omega-3 fatty acids and ribonucleic acid-supplemented diet versus
placebo in cancer patients: an immunologic evaluation of Impact. Crit Care Med
1995;23:652–9.
113. Alexander JW. Immunoenhancement via enteral nutrition. Arch
Surg 1993;128:1242–5 [review].
114. Braga M, Gianotti L, Radaelli G, et al. Perioperative
immunonutrition in patients undergoing cancer surgery: results of a randomized double-blind
phase 3 trial. Arch Surg 1999;134:428–33.
115. Saffle JR, Wiebke G, Jennings K, et al. Randomized trial of
immune-enhancing enteral nutrition in burn patients. J Trauma
1997;42:793–800.
116. Pichard C, Sudre P, Karsegard V, et al. A randomized double-blind
controlled study of 6 months of oral nutritional supplementation with arginine and omega-3
fatty acids in HIV-infected patients. Swiss HIV Cohort Study. AIDS
1998;12:53–63.
117. Micke P, Beeh KM, Buhl R. Effects of long-term supplementation with
whey proteins on plasma glutathione levels of HIV-infected patients. Eur J Nutr
2002;41:12–8.
118. Wong KF, Middleton N, Montgomery M, et al. Immunostimulation of
murine spleen cells by materials associated with bovine milk protein fractions. J Dairy Sci
1998;81:1825–32.
119. Cross ML, Gill HS. Modulation of immune function by a modified
bovine whey protein concentrate. Immunol Cell Biol 1999;77:345–50.
120. Minehira K, Inoue S, Nonaka M, et al. Effects of dietary protein
type on oxidized cholesterol-induced alteration in age-related modulation of lipid metabolism
and indices of immune function in rats. Biochim Biophys Acta 2000;1483:141–53.
121. See DM, Broumand N, Sahl L, Tilles JG. In vitro effects of echinacea
and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and
chronic fatigue syndrome or acquired immunodeficiency syndrome patients.
Immunopharmacology 1997;35:229–35.
122. Melchart D, Linde K, Worku F, et al. Immunomodulation with
echinacea—a systematic review of controlled clinical trials. Phytomedicine
1994;1:245–54.
123. Melchart D, Linde K, Worku F, et al. Results of five randomized
studies on the immunomodulatory activity of preparations of echinacea. J Alt Compl
Med 1995;1:145–60.
124. Cáceres DD, Hancke JL, Burgos RA, et al. Use of visual analogue
scale measurements (VAS) to assess the effectiveness of standardized Andrographis
paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double
blind-placebo study. Phytomedicine 1999;6:217–23.
125. Cáceres DD, Hancke JL, Burgos RA, et al. Prevention of common
colds with Andrographis paniculata dried extract. A pilot double blind trial.
Phytomedicine 1997;4:101–4.
126. Bone K. The story of Andrographis paniculata, a new
“immune system” herb. Nutrition & Healing 1998;Sep:3,4,8,9
[review].
127. Scaglione F, Ferrara F, Dugnani S, et al. Immunomodulatory effects
of two extracts of Panax ginseng CA Meyer. Drugs Exptl Clin Res
1990;16:537–42.
128. Baranov AI. Medicinal uses of ginseng and related plants in the
Soviet Union: Recent trends in the Soviet literature. J Ethnopharmacol
1982;6:339–53 [review].
129. Wagner H, Nörr H, Winterhoff H. Plant adaptogens.
Phytomedicine 1994;1:63–76.
130. Bone K. Clinical Applications of Ayurvedic and Chinese
Herbs. Queensland, Australia: Phytotherapy Press, 1996, 137–41.
131. Bone K, Morgan M. Clinical Applications of Ayurvedic and Chinese
Herbs. Warwick, Queensland, Australia: Phytotherapy Press, 1996, 13–20.
132. Nanba H. Antitumor activity of orally administered
‘D-fraction’ from maitake mushroom (Grifola frondosa). J Naturopathic Med
1993;4:10–5.
133. Pengelly A. Medicinal fungi of the world. Modern
Phytotherapist 1996;2:1, 3–8 [review].
134. Keplinger H. Oxindole alkaloids having properties stimulating the
immunologic system and preparation containing same. US Patent no. 5,302,611, April 12,
1994.
135. Zhu JL, Liu C. Modulating effects of extractum semen persicae and
cultivated cordyceps hyphae on immuno-dysfunction of inpatients with posthepatitic cirrhosis.
Zhongguo Zhong Xi Yi Jie He Za Zhi 1992;12(4):207–9, 195 [in Chinese.
136. Nakamura K, Yamaguchi Y, Kagota S, et al. Activation of in vivo
Kupffer cell function by oral administration of Cordyceps sinensis in rats. Jpn J
Pharmacol 1999;79:505–8.
137. Stoner GD, Mukhtar H. Polyphenols as cancer chemopreventive agents.
J Cell Biochem Suppl 1995;22:169–80.
138. You SQ. Study on feasibility of Chinese green tea polyphenols (CTP)
for preventing dental caries. Chin J Stom 1993;28(4):197–9.
139. Hamilton-Miller JM. Antimicrobial properties of tea (Camellia
sinensis L.). Antimicrob Agents Chemother 1995;39:2375–7.
140. Foster S, Chongxi Y. Herbal Emissaries: Bringing Chinese Herbs
to the West. Rochester, VT: Healing Arts Press, 1992, 79–85.
141. Leung AY, Foster S. Encyclopedia of Common Natural Ingredients
Used in Foods, Drugs, and Cosmetics, 2d ed. New York: John Wiley & Sons, 1996,
350–2.
142. Hirazumi A, Furusawa E, Chou SC, Hokama Y. Immunomodulation
contributes to the anticancer activity of morinda citrifolia (noni) fruit juice. Proc West
Pharmacol Soc 1996;39:7–9 .
143. Herbert TB, Cohen S. Stress and immunity in humans: a meta-analytic
review. Psychosom Med 1993;55:364–79 [review].
144. Palmblad JE. Stress-related modulation of immunity: a review of
human studies. Cancer Detect Prev Suppl 1987;1:57–64 [review].
145. Kemeny ME, Gruenewald TL. Psychoneuroimmunology update. Semin
Gastrointest Dis 1999;10:20–9 [review].
146. Halley FM. Self-regulation of the immune system through
biobehavioral strategies. Biofeedback Self Regul 1991;16:55–74 [review].
147. Whitehouse WG, Dinges DF, Orne EC, et al. Psychosocial and immune
effects of self-hypnosis training for stress management throughout the first semester of
medical school. Psychosom Med 1996;58:249–63.